Enzo scores $7M in patent battle with PerkinElmer

Enzo Biochem ($ENZ) picked up a $7 million settlement in its ongoing patent squabble with PerkinElmer ($PKI), resolving one of its many legal wrangles in life sciences. The suit was tied to alleged infringement of intellectual property related to diagnostics and sequencing, and Enzo has pursued similar claims against Roche Diagnostics ($RHHBY), LabCorp ($LH), Life Technologies and Affymetrix ($AFFY). News

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.